ScoreWhy is Shanghai Allist Pharmaceuticals Co., Ltd. ?
1
The company has declared Positive results for the last 10 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 1,650.21 MM
- NET SALES(HY) At CNY 2,095.44 MM has Grown at 50.36%
- ROCE(HY) Highest at 30.82%
2
With ROE of 29.16%, it has a attractive valuation with a 7.73 Price to Book Value
- Over the past year, while the stock has generated a return of 59.43%, its profits have risen by 65.8%
3
Consistent Returns over the last 3 years
- Along with generating 59.43% returns in the last 1 year, the stock has outperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Shanghai Allist Pharmaceuticals Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai Allist Pharmaceuticals Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Allist Pharmaceuticals Co., Ltd.
-100.0%
1.35
40.83%
China Shanghai Composite
15.19%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
144.19%
EBIT Growth (5y)
69.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.55
Tax Ratio
13.82%
Dividend Payout Ratio
20.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.87%
ROE (avg)
10.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
7.73
EV to EBIT
23.49
EV to EBITDA
22.98
EV to Capital Employed
20.30
EV to Sales
10.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
86.39%
ROE (Latest)
29.16%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend29What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,650.21 MM
NET SALES(HY)
At CNY 2,095.44 MM has Grown at 50.36%
ROCE(HY)
Highest at 30.82%
DEBT-EQUITY RATIO
(HY)
Lowest at -64.66 %
INVENTORY TURNOVER RATIO(HY)
Highest at 4.55%
DEBTORS TURNOVER RATIO(HY)
Highest at 11.99%
RAW MATERIAL COST(Y)
Fallen by -2.72% (YoY
CASH AND EQV(HY)
Highest at CNY 6,994.94 MM
OPERATING PROFIT(Q)
Highest at CNY 446.43 MM
NET PROFIT(Q)
Highest at CNY 400.63 MM
EPS(Q)
Highest at CNY 0.91
-2What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 1,213,591.06
Here's what is working for Shanghai Allist Pharmaceuticals Co., Ltd.
Operating Cash Flow
Highest at CNY 1,650.21 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 1,082.9 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Debt-Equity Ratio
Lowest at -64.66 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 4.55% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 11.99% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
At CNY 1,082.9 MM has Grown at 23.43%
over average net sales of the previous four periods of CNY 877.32 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 446.43 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Net Profit
Highest at CNY 400.63 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.91
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Cash and Eqv
Highest at CNY 6,994.94 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -2.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Allist Pharmaceuticals Co., Ltd.
Interest Coverage Ratio
Lowest at 1,213,591.06
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
